HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Giovagnoli, A R Articles by Boiardi, A Search for Related Content PubMed PubMed Citation Articles by Giovagnoli, A R Articles by Boiardi, A Related Collections Neuropathology Other Neurology Cancer:other

Facets and determinants of quality of life in patients with recurrent high grade glioma

¹ Department of Neurology and Neuropathology, Carlo Besta National Neurological Institute, Via Celoria 11, 20133 Milan, Italy
² Department of Neuro-Oncology, Carlo Besta National Neurological Institute

Correspondence to:
Correspondence to:
Dr A R Giovagnoli
Department of Neurology and Neuropathology, Carlo Besta National Neurological Institute, Via Celoria 11, 20133 Milan, Italy; rgiovagnoli{at}istituto-besta.it

Objectives: To assess patients with recurrent high grade brain glioma with the aim of evaluating facets of quality of life (QOL) and their association with mood, cognition, and physical performance.

Methods: Ninety four glioma patients (four groups with different duration of glioma recurrence) were compared with 24 patients with other chronic neurological diseases and 48 healthy subjects. The Functional Living Index—Cancer (FLIC) provided QOL self evaluations, and standardised scales and neuropsychological tests assessed physical performance, mood, and cognition.

Results: In glioma patients, factor analysis of the FLIC items documented five domains: Psychological well being, Role/sociability, Inner experience of disease, Isolation/sharing, and Nausea. Higher FLIC total scores were related to better cognition, physical performances, and mood, and lower grading; poorer Psychological well being and worse Inner experience of disease to depressed mood; minor Role/sociability to worse cognitive and physical performances and higher grading; worse Nausea to longer disease duration. Compared with healthy subjects, all glioma groups were cognitively impaired and more anxious, and two groups with short duration of recurrence were also more depressed. Patients with chronic neurological diseases showed worse mood and cognitive abilities compared with healthy subjects, but performed attention tests better than glioma patients. Glioma and chronic disease patients showed similar FLIC scores and autonomy.

Conclusions: These results show that QOL of recurrent high grade glioma patients is multifaceted and determined by multiple factors. Disease severity does not necessarily eliminate the possibility of expressing personal feelings and opinions which could provide criteria for clinical decision making and psychological support.

Abbreviations: ADL, Activity Daily Living; AM, Attentive Matrices; FLIC, Functional Living Index—Cancer; KPS, Karnofsky Performance Status; QOL, quality of life; RCPM, Raven’s Coloured Progressive Matrices; SR, Story Recall; SRDS, Self Rating Depression Scale; STAI1/2, State Trait Anxiety Inventory 1/2; TMTA/B, Trail Making Test A/B

Keywords: quality of life; brain glioma; mood; cognitive abilities; physical performance